Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Rheonix
company
About
RHEONIX develops automated molecular testing solutions for interchangeable purification, amplification and detection.
- 51 - 100
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $28.60M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Homeland Security,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Rheonix, Inc. operates as a biomedical device company. Its products include CARD (Chemistry And Reagent Device) system to miniaturize and automate new and existing assays in multiple fields. Its products and technology are used in human/veterinary in vitro diagnostics, food/water testing, SNP analysis for personalized medicine applications, homeland security/defense applications, process control and final product QC, and tissue culture analysis in a research or production setting. Rheonix, Inc. was founded in 2007 and is based in Ithaca, New York.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$28.60M
Rheonix has raised a total of
$28.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 13, 2019 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 13, 2019 | Convertable Note | — | 1 | — | — | Detail |
| Oct 20, 2015 | Series Unknown | $28.60M | 2 | — | — | Detail |
| Jun 18, 2015 | Debt Financing | — | 1 | — | — | Detail |
| Jul 1, 2014 | Debt Financing | — | 1 | — | — | Detail |
| Oct 25, 2013 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Rheonix is funded by 2 investors.
Advantage Capital
and Onondaga Venture Capital Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Convertable Note |
Onondaga Venture Capital Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
